FLUENT (TIUM.U) Q1 2026 earnings summary

Executive summary

• Q1 2026 revenue was $17.9M, down from $22.9M year-over-year, reflecting ongoing retail price pressure in Florida.

• Operating expenses were reduced by over 20% year-over-year as part of cost-saving initiatives.

• Net loss from continuing operations was $14.9M, compared to a net loss of $9.1M in Q1 2025.

• Adjusted EBITDA was $1.3M, down from $4.1M year-over-year.

• Ended the quarter with $8.3M in cash and $78.8M in total debt.

Financial highlights

• Gross profit before fair value adjustments was $5.5M (30.8% margin), down from $11.1M (48.5%) year-over-year.

• Cash flow used in operations was $1.9M, compared to $1.5M in Q1 2025.

• Adjusted EBITDA decreased primarily due to lower retail prices and reduced fair value of biological assets.

• Net loss per share from continuing operations was $(0.02), unchanged year-over-year.

Outlook and guidance

• Additional cost savings expected to materialize in Q2 2026 from ongoing optimization initiatives.

• Strategic transactions underway: Vireo acquisition and Texas divestiture, both aimed at improving liquidity.

• Management acknowledges significant doubt about the ability to continue as a going concern, pending successful completion of strategic initiatives.